These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9080857)

  • 1. Genetic markers of ventricular hypertrophy.
    Hauser RG
    Am J Cardiol; 1997 Mar; 79(6A):12-5. PubMed ID: 9080857
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for gene assays for cardiomyopathy in children].
    Subspecialty Group of Cardiology, The Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):595-7. PubMed ID: 24225290
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of hypertrophic and dilated cardiomyopathy.
    Marian AJ; Roberts R
    Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sudden death due to genetic and biochemical disorders--hypertropic cardiomyopathy].
    Nishi H
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):3-9. PubMed ID: 9513540
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.
    Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M
    J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to cardiomyopathies.
    Abdulla R
    Pediatr Cardiol; 1997; 18(4):260. PubMed ID: 9175520
    [No Abstract]   [Full Text] [Related]  

  • 11. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age.
    Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M
    Am J Cardiol; 2001 Jun; 87(11):1315-7. PubMed ID: 11377367
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
    Tajsharghi H; Fyhr IM
    Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 17. Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy.
    Schmitt JP; Semsarian C; Arad M; Gannon J; Ahmad F; Duffy C; Lee RT; Seidman CE; Seidman JG
    Circulation; 2003 Sep; 108(9):1133-8. PubMed ID: 12925456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular aspects of cardiac hypertrophy and their implications in cardiomyopathies].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):223-7. PubMed ID: 10885318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies.
    Meder B; Haas J; Keller A; Heid C; Just S; Borries A; Boisguerin V; Scharfenberger-Schmeer M; Stähler P; Beier M; Weichenhan D; Strom TM; Pfeufer A; Korn B; Katus HA; Rottbauer W
    Circ Cardiovasc Genet; 2011 Apr; 4(2):110-22. PubMed ID: 21252143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.